Health
2nd study testing a COVID-19 antibody drug has a setback – Economic Times
Tests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is very sick, the drugs…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
-
Noosa News13 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business16 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General12 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Business20 hours agoIs AustralianSuper buying or selling Telstra and CSL shares?